LncRNAs: the Bridge Linking RNA and Colorectal Cancer.
Yanfei Yang,Linjie Zhao,Lingzi Lei,Wayne Bond Lau,Bonnie Lau,Qilian Yang,Xiaobing Le,Huiliang Yang,Chenlu Wang,Zhongyue Luo,Yu Xuan,Yi Chen,Xiangbing Deng,Lian Xu,Min Feng,Tao Yi,Xia Zhao,Yuquan Wei,Shengtao Zhou
DOI: https://doi.org/10.18632/oncotarget.13573
2016-01-01
Oncotarget
Abstract:Long noncoding RNAs (lncRNAs) are transcribed by genomic regions (exceeding 200 nucleotides in length) that do not encode proteins. While the exquisite regulation of lncRNA transcription can provide signals of malignant transformation, lncRNAs control pleiotropic cancer phenotypes through interactions with other cellular molecules including DNA, protein, and RNA. Recent studies have demonstrated that dysregulation of lncRNAs is influential in proliferation, angiogenesis, metastasis, invasion, apoptosis, stemness, and genome instability in colorectal cancer (CRC), with consequent clinical implications. In this review, we explicate the roles of different lncRNAs in CRC, and the potential implications for their clinical application.